eLife assessment: DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancersMark Linchcrossref(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要